Output details
12 - Aeronautical, Mechanical, Chemical and Manufacturing Engineering
University of Cambridge
Article title
Identification of a biological signature for schizophrenia in serum
Type
D - Journal article
DOI
-
Title of journal
Molecular Psychiatry
Article number
-
Volume number
17
Issue number
5
First page of article
494
ISSN of journal
1359-4184
Year of publication
2012
URL
-
Number of additional authors
20
Additional information
This is the first study which proved that these conditions can be detected by changes in the levels of molecules in the blood. This work led to the development of blood-based biomarker test for schizophrenia in a clinical setting (www.veripsych.com/ contact available on request). The follow up has involved extensive collaboration with clinical psychiatrists in Germany, The Netherlands and the USA, and with the Myriad-RBM biomarker facility in Austin, Texas, USA (contact available on request) in efforts to identify biomarker tests for schizophrenia, depression and bipolar disease.
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-
